Hearing loss has been rarely reported in Takayasu's arteritis, may present as Sudden Sensorineural Hearing Loss, and usually responds well to corticosteroid therapy. Hyperbaric Oxygen Therapy is commonly used as a supplementary treatment to corticosteroids for Sudden Sensorineural Hearing Loss. We present the case of a 36-year-old woman with Takayasu's arteritis who had two episodes of sudden hearing loss involving one ear at a time with an 11-month delay between each episode. During the first episode, the patient was treated with high-dose intramuscular corticosteroids with a temporary improvement of auditory threshold that deteriorated 14 days after cessation of therapy. In the second episode, Hyperbaric Oxygen Therapy was associated with corticosteroids, with improvements in both ears, including the one that was unresponsive in the long term to previous pharmacologic therapy. In this case, Hyperbaric Oxygen Therapy could have acted synergically with corticosteroids playing a role in hearing restoration.
http://ift.tt/2xY241w
Αρχειοθήκη ιστολογίου
-
►
2020
(289)
- ► Φεβρουαρίου (28)
-
►
2019
(9071)
- ► Δεκεμβρίου (19)
- ► Σεπτεμβρίου (54)
- ► Φεβρουαρίου (3642)
- ► Ιανουαρίου (3200)
-
►
2018
(39872)
- ► Δεκεμβρίου (3318)
- ► Σεπτεμβρίου (3683)
- ► Φεβρουαρίου (2693)
- ► Ιανουαρίου (3198)
-
▼
2017
(41099)
- ► Δεκεμβρίου (3127)
-
▼
Σεπτεμβρίου
(2173)
-
▼
Σεπ 10
(40)
- Perceptual Visual Skills in Delayed Language Devel...
- Helicobacter pylori infection and extragastric dis...
- Genomics of Helicobacter pylori
- Gastric cancer: Basic aspects
- Other Helicobacters, gastric and gut microbiota
- Diagnosis of Helicobacter pylori infection
- Helicobacter: Inflammation, immunology and vaccines
- Abstracts
- Keyword Index
- Pathogenesis of Helicobacter pylori infection
- Treatment of Helicobacter pylori infection 2017
- Epidemiology of Helicobacter pylori infection
- Helicobacter pylori, gastric cancer and other gast...
- Issue Information
- Helicobacter pylori infection in children
- 30th anniversary of the European helicobacter & mi...
- Author Index
- Helicobacter pylori infection and nonmalignant dis...
- Adenocarcinoma of the lacrimal gland: a case report
- The new targeted therapy in systemic lupus erythem...
- Can we withdraw anticoagulation in patients with a...
- Humanistic and cost burden of systemic sclerosis: ...
- Is PET/CT essential in the diagnosis and follow-up...
- Neutrophil extracellular traps (NETs) in autoimmun...
- Should we treat congenital heart block with fluori...
- Bone mineral density and vitamin D status in syste...
- Is ACPA positivity the main driver for rheumatoid ...
- Cytotoxicity and potential anti-inflammatory activ...
- Alternate dosing regimens of brentuximab vedotin f...
- Chronic actinic dermatitis: successful treatment w...
- Alternate dosing regimens of brentuximab vedotin f...
- The value and pitfalls of biologics registries for...
- Registries as a real-world cohort studies that are...
- Recovery from Repeated Sudden Hearing Loss in a Pa...
- Injection Volume and Anesthetic Effect in Serratus...
- Delineating the Trajectory of Cognitive Recovery F...
- Postoperative Complications Affecting Survival Aft...
- The Assignment of American Society of Anesthesiolo...
- Radiofrequency Treatments on the Spine, 1st ed.
- Descriptive Statistics: Reporting the Answers to t...
-
▼
Σεπ 10
(40)
-
►
2016
(13807)
- ► Δεκεμβρίου (700)
- ► Σεπτεμβρίου (600)
- ► Φεβρουαρίου (1350)
- ► Ιανουαρίου (1400)
-
►
2015
(1500)
- ► Δεκεμβρίου (1450)
Ετικέτες
Κυριακή 10 Σεπτεμβρίου 2017
Recovery from Repeated Sudden Hearing Loss in a Patient with Takayasu’s Arteritis Treated with Hyperbaric Oxygen Therapy: The First Report in the Literature
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου